Laboratorios Farmaceuticos Rovi, S.A.
MSE:ROVI.MC
Overview | Financials
Company Name | Laboratorios Farmaceuticos Rovi, S.A. |
Symbol | ROVI.MC |
Currency | EUR |
Price | 79.9 |
Market Cap | 4,084,362,637 |
Dividend Yield | 1.52% |
52-week-range | 46.78 - 94.8 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Juan Lopez-Belmonte Encina |
Website | https://www.rovi.es |
An error occurred while fetching data.
About Laboratorios Farmaceuticos Rovi, S.A.
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, production, and sale of pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company distributes other products that are licensed from other laboratories. Its principal products include Hibor, a low-molecular-weight heparin to prevent and treat venous thromboembolic disease; Enoxaparin
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD